CitraNOX 120 CT by Ortho Molecular Products
CitraNOX by Ortho Molecular Products is a dietary supplement designed to support cardiovascular health by maintaining normal inflammatory balance, nitric oxide (NO) levels, smooth muscle integrity, and optimizing vasodilation of key coronary arteries.* It may also reduce the impact of stress on your vascular arteries caused by aging.*
Who Is CitraNOX 120 CT for?
CitraNOX 120 CT by Ortho Molecular Products may support your health if you:
- struggle from vascular conditions related to aging*
- seek to improve overall heart health*
CitraNOX 120 CT by Ortho Molecular Products—Effects?
CitraNOX 120 CT may have the following effects:
- supporting normal inflammatory balance and nitric oxide levels*
- maintaining smooth muscle integrity and optimizing vasodilation*
- mitigating the impact of stress on coronary arteries caused by aging*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about CitraNOX 120 CT.
Recommendation:
Ortho Molecular Products suggests taking 4 CitraNOX capsules per day or as recommended by your health care professional.
Serving Size: 4 Capsules
Servings Per Container: 30
Amount Per Serving:
L-Citrulline 3 g
Grape Seed Extract (MegaNatural®-BP) 200 mg
Quercetin Dihydrate 200 mg
Other Ingredients: Natural Vegetable Capsules, Stearic Acid, and Magnesium Stearate.
Does Not Contain: Gluten, corn, yeast, artificial colors and flavors.
Cautions: If you are pregnant or nursing, consult your health care professional before taking CitraNOX by Ortho Molecular Products.
References:
- Black, P. H., & Garbutt, L. D. (2002). Stress, inflammation, and cardiovascular disease. Journal of Psychosomatic Research, 52, 1–23.
- Tracy, R. (2003). Emerging relationships of inflammation, cardiovascular disease, and chronic diseases of aging. International Journal of Obesity & Related Metabolic Disorders, 27.
- Palmer, R. M., Ferrige, A., & Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
- Furchgott, R., & Jothianandan, D. (1991). Endothelium-dependent and -independent vasodilation involving cyclic GMP: Relaxation induced by nitric oxide, carbon monoxide, and light. Journal of Vascular Research, 28, 52–61.
- Vallance, P., Collier, J., & Moncada, S. (1989). Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. The Lancet, 334, 997–1000.
- Pérez-Guisado, J., & Jakeman, P. M. (2010). Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. The Journal of Strength & Conditioning Research, 24, 1215–1222.
- Bailey, S. J., Blackwell, J. R., Lord, T., Vanhatalo, A., Winyard, P. G., & Jones, A. M. (2015). L-citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans. Journal of Applied Physiology, 119, 385–395.
- Suzuki, T., Morita, M., Kobayashi, Y., & Kamimura, A. (2015). Oral L-citrulline supplementation enhances cycling time trial performance in healthy well-trained males. Journal of the International Society of Sports Nutrition, 12(P52).
- Nagaya, N., Uematsu, M., Oya, H., Sato, N., Sakamaki, F., Kyotani, S., Ueno, K., Nakanishi, N., Yamagishi, M., & Miyatake, K. (2001). Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 163, 887–891.
- Wagenmakers, A. J. (1999). Amino acid supplements to improve athletic performance. Current Opinion in Clinical Nutrition & Metabolic Care, 2, 539–544.
- Cannon, R. O. (1998). Role of nitric oxide in cardiovascular disease: Focus on the endothelium. Clinical Chemistry, 44, 1809–1819.
- Radomski, M. W., Palmer, R. M., & Moncada, S. (1987). The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochemical and Biophysical Research Communications, 148, 1482–1489.
- Napoli, C., & Ignarro, L. J. (2001). Nitric oxide and atherosclerosis. Nitric Oxide, 5, 88–97.
- Romero, M. J., Platt, D. H., Caldwell, R. B., & Caldwell, R. W. (2006). Therapeutic use of citrulline in cardiovascular disease. Cardiovascular Drug Reviews, 24, 275–290.
- Durante, W., Johnson, F. K., & Johnson, R. A. (2007). Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clinical and Experimental Pharmacology and Physiology, 34, 906–911.
- Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H., Nakane, M., & Murad, F. (1991). Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proceedings of the National Academy of Sciences, 88, 10480–10484.
- Morris, S. M. (2006). Arginine: Beyond protein. The American Journal of Clinical Nutrition, 83, 508S–512S.
- Ryall, J. C., Quantz, M. A., & Shore, G. C. (1986). Rat liver and intestinal mucosa differ in the developmental pattern and hormonal regulation of carbamoyl-phosphate synthetase I and ornithine carbamoyl transferase gene expression. European Journal of Biochemistry, 156, 453–458.
- Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008). Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: Impact on nitric oxide metabolism. British Journal of Clinical Pharmacology, 65, 51–59.
- Morita, M., Hayashi, T., Ochiai, M., Maeda, M., Yamaguchi, T., Ina, K., & Kuzuya, M. (2014). Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability. Biochemical and Biophysical Research Communications, 454, 53–57.
- Bito, T., Roy, S., Sen, C. K., Shirakawa, T., Gotoh, A., Ueda, M., Ichihashi, M., & Packer, L. (2002). Flavonoids differentially regulate IFNγ-induced ICAM-1 expression in human keratinocytes: Molecular mechanisms of action. FEBS Letters, 520, 145–152.
- Min, Y. D., Choi, C. H., Bark, H., Son, H. Y., Park, H. H., Lee, S., Park, J. W., Park, E. K., Shin, H. I., & Kim, S. H. (2007). Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-κB and p38 MAPK in HMC-1 human mast cell line. Inflammation Research, 56, 210–215.
- Sanchez, M., Galisteo, M., Vera, R., Villar, I. C., Zarzuelo, A., Tamargo, J., Pérez-Vizcaíno, F., & Duarte, J. (2006). Quercetin downregulates NADPH oxidase, increases eNOS activity, and prevents endothelial dysfunction in spontaneously hypertensive rats. Journal of Hypertension, 24, 75–84.
- Plotnick, G. D., Corretti, M. C., Vogel, R. A., Hesslink, R., & Wise, J. A. (2003). Effect of supplemental phytonutrients on impairment of the flow-mediated brachial artery vasoactivity after a single high-fat meal. Journal of the American College of Cardiology, 41, 1744–1749.
- Edirisinghe, I., Burton-Freeman, B., & Kappagoda, C. T. (2008). Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract. Clinical Science, 114, 331–337.
- Sivaprakasapillai, B., Edirisinghe, I., Randolph, J., Steinberg, F., & Kappagoda, T. (2009). Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism, 58, 1743–1746.
1 Review Hide Reviews Show Reviews
-
CitraNOX
I can verify this product is an affective product . I have been using this product for about 3 months now and for all the benefits that is stated for me a man of 64 years in age has given me a certain satisfaction and confidence to areas of my health.